Skip to main content
TipRanks
Go Ultimate75% OFF

Thomas Hughes Insider Profile

4 Followers

Thomas Hughes, Director at Viridian Therapeutics, holds 12.83K shares in Viridian Therapeutics (Ticker: VRDN), holds 125.25K shares in Larimar Therapeutics (Ticker: LRMR). Most recently, Thomas Hughes Bought ― shares of Viridian Therapeutics on Oct 12, 2018 for an estimated value of $47.60K.

Thomas Hughes's Trading History

VRDN
Viridian Therapeutics
Oct 12, 2018DirectorInformative Buy47.60K$395.97K
LRMR
Larimar Therapeutics
Jun 29, 2018President and Chief Scientific Officer, DirectorUninformative Sell320.00K$378.25K

You May Also Like

Thomas Hughes insider profile FAQ

What is the percentage of profitable transactions made by Thomas Hughes?
The percentage of profitable transactions made by Thomas Hughes is 50%.
What is the average return per transaction made by Thomas Hughes?
The average return per transaction made by Thomas Hughes is -35.10%.
What stocks does Thomas Hughes hold?
Thomas Hughes holds: VRDN, LRMR stocks.
What was Thomas Hughes’s latest transaction?
Thomas Hughes’s latest transaction was an Informative Buy of $47.60K.
What was Thomas Hughes's most profitable transaction?
Thomas Hughes’s most profitable transaction was an Informative Buy of LRMR stock on August 31, 2016. The return on the trade was 20.70%.
What is Thomas Hughes's role in Viridian Therapeutics?
Thomas Hughes's role in Viridian Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.